(Q77940062)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9929751%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

title

Long-term safety of pravastatin-gemfibrozil therapy in mixed hyperlipidemia (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9929751%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

1 reference

E A Iliadis

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9929751%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

R S Rosenson

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9929751%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

publication date

1 January 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9929751%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9929751%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

volume

22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9929751%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9929751%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

page(s)

25-28

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9929751%20AND%20SRC:MED&resulttype=core&format=json

Gemfibrozil-lovastatin therapy for primary hyperlipoproteinemias

9 December 2019

cites work

1 reference

12 December 2020

Rhabdomyolysis associated with lovastatin and erythromycin use.

1 reference

12 December 2020

Myopathy and rhabdomyolysis associated with lovastatin-gemfibrozil combination therapy

1 reference

12 December 2020

Rhabdomyolysis in patients receiving lovastatin after cardiac transplantation

1 reference

12 December 2020

Rhabdomyolysis and renal injury with lovastatin use. Report of two cases in cardiac transplant recipients

1 reference

12 December 2020

Lovastatin, nicotinic acid, and rhabdomyolysis

1 reference

12 December 2020

Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

1 reference

12 December 2020

[Rhabdomyolysis in patients treated with simvastatin and cyclosporin: role of the hepatic cytochrome P450 enzyme system activity]

1 reference

12 December 2020

Rhabdomyolysis from the coadministration of lovastatin and the antifungal agent itraconazole

1 reference

12 December 2020

Recent advances: the cytochrome P450 enzymes.

1 reference

12 December 2020

Safety of combined pravastatin-gemfibrozil therapy

1 reference

12 December 2020

Pravastatin and gemfibrozil alone and in combination for the treatment of hypercholesterolemia

1 reference

12 December 2020

Gemfibrozil-lovastatin-associated myalgia

1 reference

12 December 2020

Efficacy and safety of a new HMG-CoA reductase inhibitor, atorvastatin, in patients with hypertriglyceridemia

1 reference

12 December 2020

Differential sensitivity of C2-C12 striated muscle cells to lovastatin and pravastatin

1 reference

12 December 2020

Effects of atorvastatin, an HMG-CoA reductase inhibitor, on hepatic oxidative metabolism of antipyrine

1 reference

12 December 2020

In vitro comparative inhibition profiles of major human drug metabolising cytochrome P450 isozymes (CYP2C9, CYP2D6 and CYP3A4) by HMG-CoA reductase inhibitors

1 reference

12 December 2020

Effect of combination therapy with lipid-reducing drugs in patients with coronary heart disease and "normal" cholesterol levels. A randomized, placebo-controlled trial. Harvard Atherosclerosis Reversibility Project (HARP) Study Group

1 reference

12 December 2020

Myositis and rhabdomyolysis associated with concurrent use of simvastatin and nefazodone

1 reference

12 December 2020

Metabolism of cerivastatin by human liver microsomes in vitro. Characterization of primary metabolic pathways and of cytochrome P450 isozymes involved

1 reference

12 December 2020

Safety and efficacy of long-term statin-fibrate combinations in patients with refractory familial combined hyperlipidemia

1 reference

12 December 2020

Identifiers

DOI

10.1002/CLC.4960220110

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9929751%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9929751%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

PubMed publication ID

9929751

1 reference